{"id":2390,"date":"2025-12-18T08:23:22","date_gmt":"2025-12-18T08:23:22","guid":{"rendered":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/"},"modified":"2025-12-18T08:23:22","modified_gmt":"2025-12-18T08:23:22","slug":"olandijoje-isikurusi-targed-surinko-215-mln","status":"publish","type":"post","link":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","title":{"rendered":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln."},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<p><span style=\"font-weight: 400;\">Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 <strong>\u201eTargED Biopharmaceuticals\u201c. <\/strong>paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos finansavimas dabar vir\u0161ija 60 mln.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><em>&#8222;TGD001 impulsas ir toliau stipr\u0117ja \u2013 nuo \u200b\u200b\u012ftikinam\u0173 ikiklinikini\u0173 duomen\u0173 iki skatinan\u010di\u0173 pirm\u0105j\u012f klinikin\u012f naudojim\u0105 \u2013 ir \u0161is finansavimas leid\u017eia mums ry\u017etingai pereiti \u012f kit\u0105 pl\u0117tros etap\u0105. Manome, kad TGD001 gali i\u0161 esm\u0117s pakeisti tromboz\u0117s gydym\u0105, si\u016blydamas nauj\u0105 po\u017ei\u016br\u012f \u012f visuotin\u012f kre\u0161uli\u0173 tirpim\u0105 \u012fvairiose indikacijose&#8221;, &#8211; sak\u0117 jis.<\/em> pasak\u0117 <strong>Kristofas \u200b\u200bVerkruysas<\/strong>\u201eTargED Biopharmaceuticals\u201c generalinis direktorius ir vienas i\u0161 \u012fk\u016br\u0117j\u0173. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">\u0160\u012f Utrechto universiteto medicinos centro padalin\u012f 2020 m. \u012fk\u016br\u0117 Coenas Maasas, Stevenas de Maatas, Marcas van Moorselis ir Kristofas \u200b\u200bVercruysse&#8217;as. TargED rei\u0161kia Targeted Enzyme Delivery, o \u012fmon\u0117 kuria tikslinius trombozini\u0173 lig\u0173 gydymo b\u016bdus. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Jo \u0161vino junginys yra TGD001, tikslinis trombolizinis preparatas, skirtas \u012fvairiems tromboz\u0117s rei\u0161kiniams gydyti. Kaip antik\u016bn\u0173 ir ferment\u0173 sulietas baltymas, TGD001 jungiasi prie von Willebrand faktoriaus (VWF) ir skatina specifin\u012f kre\u0161ulio skilim\u0105, veikiant fermentui urokinazei, paai\u0161kino TargED. <\/span><\/p>\n<p><span style=\"font-weight: 400;\">Toliau ai\u0161kindama TGD001 prana\u0161um\u0105 prie\u0161 kitus \u0161iuo metu patvirtintus gydymo b\u016bdus, oland\u0173 bendrov\u0117 pamin\u0117jo, kad trombolizinis preparatas padidina VWF buvim\u0105 visuose kre\u0161uliuose, o tai leid\u017eia pla\u010diai suskaidyti kre\u0161ul\u012f, nes suardomas ir VWF, ir fibrinas.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Anks\u010diau \u0161\u012f m\u0117nes\u012f bendrov\u0117 prane\u0161\u0117 apie teigiamus pirmojo etapo \u017emogaus rezultatus <\/span><span style=\"font-weight: 400;\">TGD001, nurodydamas palank\u0173 saugumo profil\u012f ir stipr\u0173 trombolizin\u012f aktyvum\u0105. Jis bus toliau tobulinamas \u016bminiam i\u0161eminiam insultui (AIS) ir trombozinei mikroangiopatijai (TMA), \u012fskaitant imunin\u0119 trombozin\u0119 trombocitopenin\u0119 purpur\u0105 (iTTP), gydyti.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Su \u0161iuo nauju finansavimu TargED siekia inicijuoti du 1\/2 faz\u0117s klinikinio koncepcijos \u012frodymo tyrimus visoje Europoje ir JAV, o pirmuosius duomenis tikimasi gauti 2026 m. \u0160i\u0173 met\u0173 prad\u017eioje, bir\u017eelio m\u0117n., bendrovei pagal EIC Accelerator program\u0105 buvo suteikta mi\u0161ri finansin\u0117 dotacija i\u0161 Europos inovacij\u0173 tarybos (EIC). Finansavimas ap\u0117m\u0117 2,5 mln. EUR dotacij\u0105 ir iki 10 mln. EUR investicij\u0173 \u012f kapital\u0105. <\/span><\/p>\n<\/div>\n<p><script>\n        !function(f,b,e,v,n,t,s)\n        {if(f.fbq)return;n=f.fbq=function(){n.callMethod?\n            n.callMethod.apply(n,arguments):n.queue.push(arguments)};\n            if(!f._fbq)f._fbq=n;n.push=n;n.loaded=!0;n.version='2.0';\n            n.queue=();t=b.createElement(e);t.async=!0;\n            t.src=v;s=b.getElementsByTagName(e)(0);\n            s.parentNode.insertBefore(t,s)}(window, document,'script',\n            'https:\/\/connect.facebook.net\/en_US\/fbevents.js');\n        fbq('init', '154586475232058');\n        fbq('track', 'PageView');\n    <\/script><br \/>\n<br \/><br \/>\n<br \/><a href=\"https:\/\/www.eu-startups.com\/2025\/12\/dutch-based-targed-raises-e21-5-million-series-a-extension-to-advance-targeted-treatments-for-thrombotic-diseases\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2391,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[3],"tags":[8,20,4743,17,4744],"class_list":["post-2390","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-finansai","tag-isikurusi","tag-mln","tag-olandijoje","tag-surinko","tag-targed"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"ji77nXn3Nbq3qB2zX2ryMrAUoWB8-dKiEe1-MVQJ42M\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"lt_LT\" \/>\n\t\t<meta property=\"og:site_name\" content=\"VienaPaskola.LT - Finansai,ekonomika,technologijos\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\" \/>\n\t\t<meta property=\"og:description\" content=\"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-12-18T08:23:22+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2025-12-18T08:23:22+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#blogposting\",\"name\":\"Olandijoje \\u012fsik\\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\",\"headline\":\"Olandijoje \\u012fsik\\u016brusi TargED surinko 21,5 mln.\",\"author\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"width\":1920,\"height\":1080},\"datePublished\":\"2025-12-18T08:23:22+00:00\",\"dateModified\":\"2025-12-18T08:23:22+00:00\",\"inLanguage\":\"lt-LT\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#webpage\"},\"articleSection\":\"FINANSAI, \\u012fsik\\u016brusi, mln, Olandijoje, surinko, TargED\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/vienapaskola.lt\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/category\\\/finansai\\\/#listItem\",\"name\":\"FINANSAI\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/category\\\/finansai\\\/#listItem\",\"position\":2,\"name\":\"FINANSAI\",\"item\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/category\\\/finansai\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#listItem\",\"name\":\"Olandijoje \\u012fsik\\u016brusi TargED surinko 21,5 mln.\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#listItem\",\"position\":3,\"name\":\"Olandijoje \\u012fsik\\u016brusi TargED surinko 21,5 mln.\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/category\\\/finansai\\\/#listItem\",\"name\":\"FINANSAI\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#organization\",\"name\":\"VienaPaskola.LT\",\"description\":\"Finansai,ekonomika,technologijos\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/#author\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#webpage\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\",\"name\":\"Olandijoje \\u012fsik\\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\",\"description\":\"Nyderland\\u0173 klinikinio etapo BioTech \\u012fmon\\u0117 \\u201eTargED Biopharmaceuticals\\u201c. paskelb\\u0117 apie 21,5 mln. eur\\u0173 A serijos prat\\u0119simo finansavimo u\\u017edarym\\u0105, kad paspartint\\u0173 tikslinio trombolizinio preparato TGD001 klinikin\\u012f vystym\\u0105si. Tur\\u0105 ved\\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \\u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \\u0161iuo prat\\u0119simu bendras TargED A serijos\",\"inLanguage\":\"lt-LT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#mainImage\",\"width\":1920,\"height\":1080},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#mainImage\"},\"datePublished\":\"2025-12-18T08:23:22+00:00\",\"dateModified\":\"2025-12-18T08:23:22+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#website\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/\",\"name\":\"VienaPaskola.LT\",\"description\":\"Finansai,ekonomika,technologijos\",\"inLanguage\":\"lt-LT\",\"publisher\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","description":"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos","canonical_url":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"ji77nXn3Nbq3qB2zX2ryMrAUoWB8-dKiEe1-MVQJ42M","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#blogposting","name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","headline":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.","author":{"@id":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/#author"},"publisher":{"@id":"https:\/\/vienapaskola.lt\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","width":1920,"height":1080},"datePublished":"2025-12-18T08:23:22+00:00","dateModified":"2025-12-18T08:23:22+00:00","inLanguage":"lt-LT","mainEntityOfPage":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#webpage"},"isPartOf":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#webpage"},"articleSection":"FINANSAI, \u012fsik\u016brusi, mln, Olandijoje, surinko, TargED"},{"@type":"BreadcrumbList","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt#listItem","position":1,"name":"Home","item":"https:\/\/vienapaskola.lt","nextItem":{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/#listItem","name":"FINANSAI"}},{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/#listItem","position":2,"name":"FINANSAI","item":"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/","nextItem":{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#listItem","name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln."},"previousItem":{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#listItem","position":3,"name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.","previousItem":{"@type":"ListItem","@id":"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/#listItem","name":"FINANSAI"}}]},{"@type":"Organization","@id":"https:\/\/vienapaskola.lt\/#organization","name":"VienaPaskola.LT","description":"Finansai,ekonomika,technologijos","url":"https:\/\/vienapaskola.lt\/"},{"@type":"Person","@id":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/#author","url":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/","name":"admin","image":{"@type":"ImageObject","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin"}},{"@type":"WebPage","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#webpage","url":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","description":"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos","inLanguage":"lt-LT","isPartOf":{"@id":"https:\/\/vienapaskola.lt\/#website"},"breadcrumb":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#breadcrumblist"},"author":{"@id":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/#author"},"creator":{"@id":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#mainImage","width":1920,"height":1080},"primaryImageOfPage":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#mainImage"},"datePublished":"2025-12-18T08:23:22+00:00","dateModified":"2025-12-18T08:23:22+00:00"},{"@type":"WebSite","@id":"https:\/\/vienapaskola.lt\/#website","url":"https:\/\/vienapaskola.lt\/","name":"VienaPaskola.LT","description":"Finansai,ekonomika,technologijos","inLanguage":"lt-LT","publisher":{"@id":"https:\/\/vienapaskola.lt\/#organization"}}]},"og:locale":"lt_LT","og:site_name":"VienaPaskola.LT - Finansai,ekonomika,technologijos","og:type":"article","og:title":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","og:description":"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos","og:url":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","article:published_time":"2025-12-18T08:23:22+00:00","article:modified_time":"2025-12-18T08:23:22+00:00","twitter:card":"summary_large_image","twitter:title":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","twitter:description":"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos"},"aioseo_meta_data":{"post_id":"2390","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2025-12-18 08:32:27","updated":"2025-12-18 08:32:27","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/vienapaskola.lt\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/\" title=\"FINANSAI\">FINANSAI<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tOlandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/vienapaskola.lt"},{"label":"FINANSAI","link":"https:\/\/vienapaskola.lt\/index.php\/category\/finansai\/"},{"label":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.","link":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/"}],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/\" \/>\n<meta property=\"og:locale\" content=\"lt_LT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\" \/>\n<meta property=\"og:description\" content=\"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/\" \/>\n<meta property=\"og:site_name\" content=\"VienaPaskola.LT\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-18T08:23:22+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minut\u0117s\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#\\\/schema\\\/person\\\/fd1e0e3a6f51f419b26be8373355ab9b\"},\"headline\":\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.\",\"datePublished\":\"2025-12-18T08:23:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\"},\"wordCount\":361,\"image\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"keywords\":[\"\u012fsik\u016brusi\",\"mln\",\"Olandijoje\",\"surinko\",\"TargED\"],\"articleSection\":[\"FINANSAI\"],\"inLanguage\":\"lt-LT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\",\"name\":\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"datePublished\":\"2025-12-18T08:23:22+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#\\\/schema\\\/person\\\/fd1e0e3a6f51f419b26be8373355ab9b\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#breadcrumb\"},\"inLanguage\":\"lt-LT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#primaryimage\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"contentUrl\":\"https:\\\/\\\/vienapaskola.lt\\\/wp-content\\\/uploads\\\/2025\\\/12\\\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/2025\\\/12\\\/18\\\/olandijoje-isikurusi-targed-surinko-215-mln\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/vienapaskola.lt\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#website\",\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/\",\"name\":\"VienaPaskola.LT\",\"description\":\"Finansai,ekonomika,technologijos\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vienapaskola.lt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"lt-LT\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vienapaskola.lt\\\/#\\\/schema\\\/person\\\/fd1e0e3a6f51f419b26be8373355ab9b\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"lt-LT\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\\\/\\\/vienapaskola.lt\"],\"url\":\"https:\\\/\\\/vienapaskola.lt\\\/index.php\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","og_locale":"lt_LT","og_type":"article","og_title":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","og_description":"Nyderland\u0173 klinikinio etapo BioTech \u012fmon\u0117 \u201eTargED Biopharmaceuticals\u201c. paskelb\u0117 apie 21,5 mln. eur\u0173 A serijos prat\u0119simo finansavimo u\u017edarym\u0105, kad paspartint\u0173 tikslinio trombolizinio preparato TGD001 klinikin\u012f vystym\u0105si. Tur\u0105 ved\u0117 BioGeneration Ventures (BGV), dalyvaujant esamiems investuotojams, \u012fskaitant Andera Partners, Fund+, Hadean Ventures, Inkef Capital, Sunstone Life Science Ventures ir Curie Capital. Su \u0161iuo prat\u0119simu bendras TargED A serijos [&hellip;]","og_url":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","og_site_name":"VienaPaskola.LT","article_published_time":"2025-12-18T08:23:22+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minut\u0117s"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#article","isPartOf":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/"},"author":{"name":"admin","@id":"https:\/\/vienapaskola.lt\/#\/schema\/person\/fd1e0e3a6f51f419b26be8373355ab9b"},"headline":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln.","datePublished":"2025-12-18T08:23:22+00:00","mainEntityOfPage":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/"},"wordCount":361,"image":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#primaryimage"},"thumbnailUrl":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","keywords":["\u012fsik\u016brusi","mln","Olandijoje","surinko","TargED"],"articleSection":["FINANSAI"],"inLanguage":"lt-LT"},{"@type":"WebPage","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","url":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/","name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln. - VienaPaskola.LT","isPartOf":{"@id":"https:\/\/vienapaskola.lt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#primaryimage"},"image":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#primaryimage"},"thumbnailUrl":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","datePublished":"2025-12-18T08:23:22+00:00","author":{"@id":"https:\/\/vienapaskola.lt\/#\/schema\/person\/fd1e0e3a6f51f419b26be8373355ab9b"},"breadcrumb":{"@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#breadcrumb"},"inLanguage":"lt-LT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/"]}]},{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#primaryimage","url":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","contentUrl":"https:\/\/vienapaskola.lt\/wp-content\/uploads\/2025\/12\/Olandijoje-isikurusi-TargED-surinko-215-mln.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/vienapaskola.lt\/index.php\/2025\/12\/18\/olandijoje-isikurusi-targed-surinko-215-mln\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vienapaskola.lt\/"},{"@type":"ListItem","position":2,"name":"Olandijoje \u012fsik\u016brusi TargED surinko 21,5 mln."}]},{"@type":"WebSite","@id":"https:\/\/vienapaskola.lt\/#website","url":"https:\/\/vienapaskola.lt\/","name":"VienaPaskola.LT","description":"Finansai,ekonomika,technologijos","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vienapaskola.lt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"lt-LT"},{"@type":"Person","@id":"https:\/\/vienapaskola.lt\/#\/schema\/person\/fd1e0e3a6f51f419b26be8373355ab9b","name":"admin","image":{"@type":"ImageObject","inLanguage":"lt-LT","@id":"https:\/\/secure.gravatar.com\/avatar\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f37349f777250847d2fca2ada474f5a6aadffa79d5284e8ad354a5c410a691ec?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/vienapaskola.lt"],"url":"https:\/\/vienapaskola.lt\/index.php\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/posts\/2390","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/comments?post=2390"}],"version-history":[{"count":0,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/posts\/2390\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/media\/2391"}],"wp:attachment":[{"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/media?parent=2390"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/categories?post=2390"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vienapaskola.lt\/index.php\/wp-json\/wp\/v2\/tags?post=2390"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}